📣 Our #DynamX Sirolimus-Eluting Coronary #Bioadaptor System has been granted Breakthrough Device Designation by the FDA for the treatment of symptomatic ischemic heart disease. Learn more here: https://lnkd.in/ehVvSY5R #Medtech #Innovation #Cardiology CE marked. Not for sale in the U.S. PMN 1892 REV A
Incredible achievement and recent clinical performance that will have a real impact on patient lives! Well done, Motasim Sirhan and the Elixir Medical Corporation team!
Dear Motasim. Congratulations to you and all of the team members that contributed to reaching this incredibly important achievement. You are the best example I know of a true leader. You continue to exhibit courage, determination, drive, tenacity, and persistence that enables your company to successfully reach very critical milestones.
Congratulations, Elixir Team! A great step toward making this transformative technology available to U.S. patients!
Congratulations to this big achievment
Congratulations to a very smart Motasim!
Congratulations Motasim to you and the whole Elixir team!
Médico en Clínica Anzoategui
2moCongratulations Elixir team!!!!